Bluejay Diagnostics (BJDX) Operating Leases (2022 - 2026)
Bluejay Diagnostics (BJDX) reported Operating Leases of $105328.0 for Q1 2026, down 43.79% on a YoY basis from $187374.0 in Q1 2025, and up 421.14% sequentially from $20211.0 in Q4 2025.
Bluejay Diagnostics (BJDX) Operating Leases (2022 - 2026) Analysis & Trends
Bluejay Diagnostics (BJDX) has 5 years of Operating Leases data on file, last reported at $105328.0 in Q1 2026.
- For the quarter ending Q1 2026, Operating Leases fell 43.79% year-over-year to $105328.0; the trailing twelve-month figure through Mar 2026 stood at $105328.0 (down 43.79% YoY), and the FY2025 full-year result was $20211.0, down 91.42% from the prior year.
- Operating Leases improved to $105328.0 in Q1 2026, from $20211.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $513251.0 in Q4 2022 to a low of $20211.0 in Q4 2025.
- A 5-year average of $261985.1 and a median of $241652.0 in 2024 frame the typical range for Operating Leases.
- Across the five-year window, Operating Leases rose 9.8% in 2024 and tumbled 91.42% in 2025, its largest moves.
- Tracing BJDX's Operating Leases over 5 years: stood at $513251.0 in 2022, then dropped by 27.89% to $370105.0 in 2023, then plunged by 36.34% to $235623.0 in 2024, then plunged by 91.42% to $20211.0 in 2025, then soared by 421.14% to $105328.0 in 2026.
- Business Quant data shows BJDX's Operating Leases at $105328.0 in Q1 2026, $20211.0 in Q4 2025, and $42990.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Bluejay Diagnostics | 2,754.24 | 2,754.24 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 105,328.00 |
| Dec 31, 2025 | 20,211.00 |
| Sep 30, 2025 | 42,990.00 |
| Jun 30, 2025 | 165,377.00 |
| Mar 31, 2025 | 187,374.00 |
| Dec 31, 2024 | 235,623.00 |
| Sep 30, 2024 | 241,652.00 |
| Jun 30, 2024 | 279,410.00 |
| Mar 31, 2024 | 170,703.00 |
| Dec 31, 2023 | 370,105.00 |
| Sep 30, 2023 | 220,093.00 |
| Jun 30, 2023 | 424,019.00 |
| Mar 31, 2023 | 289,910.00 |
| Dec 31, 2022 | 513,251.00 |
| Sep 30, 2022 | 356,523.00 |
| Jun 30, 2022 | 430,116.00 |
| Mar 31, 2022 | 401,061.00 |